Frequency of administration of erythropoiesis‐stimulating agents for the anaemia of end‐stage kidney disease in dialysis patients

Overview of attention for article published in Cochrane database of systematic reviews, May 2014

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (76th percentile)
Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 8 X users

f1000: 1 research highlight platform

Citations

dimensions_citation: 15 Dimensions

Readers on

mendeley: 164 Mendeley
citeulike: 1 CiteULike

Summary X Research highlights Dimensions citations

So far, Dimensions has found 15 publications that cite this research output.

15

The most recent citing publications are shown below. View all 15 publications that cite this research output on Dimensions.

The Influence of Precursor Depletion and dose Regimens on Resistance to Erythropoiesis-Stimulating Agents: Insights from Simulations with Instantaneous Dose-Adaptation Algorithm

Article in Journal of Pharmaceutical Sciences (October 2023)

Monthly Continuous Erythropoietin Receptor Activator Versus Weekly Epoetin-Beta, Similar Hemoglobinization but Different Anisocytosis Degree in Hemodialysis Patients: A Randomized Controlled Trial

Article in Journal of Hematology (November 2021)

Managing Anemia across the Stages of Kidney Disease in Those Hyporesponsive to Erythropoiesis-Stimulating Agents

Article in American Journal of Nephrology (July 2021)

This page shows the most recent citations of this research output.

Click here to find out how to access more activity.